Skip to Content

C210 (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 600 mg / 200 mg / 300 mg)

Pill with imprint C210 is Pink, Capsule-shape and has been identified as Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 600 mg / 200 mg / 300 mg. It is supplied by Cipla USA Inc..

Efavirenz/emtricitabine/tenofovir is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class antiviral combinations. There is positive evidence of human fetal risk during pregnancy. Efavirenz/emtricitabine/tenofovir 600 mg / 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C210

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate

Imprint
C210
Strength
600 mg / 200 mg / 300 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
Manufacturer
Genvion Corporation
National Drug Code (NDC)
69097-0210

Get help with Imprint Code FAQs.

Related Images for "C210"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.